Loading stock data...
Eli Lilly and Company (LLY) Stock Price, Chart & Analysis
Eli Lilly and CompanyLLY
Market Closed$639.43
+$4.21+0.66%
LLY Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for LLY to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Eli Lilly and Company (LLY)
Loading chart data...
Is Eli Lilly and Company (LLY) Stock a Buy in 2025?
YES
STRONG BUY
Score: 100/100
Yes, LLY stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether LLY stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 32.0%
- Strong profit margins of 25.9%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 41.8% upside potential
- Large-cap stability with established market position
Risk Factors
- High debt-to-equity ratio of 217.89
- Moderate current ratio suggests adequate liquidity
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$906.43
Upside Potential:41.8%
Investment Summary
LLY presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 32.0%, though analyst price targets suggest 41.8% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 217.89, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:100/100
Strong Buy
2030 Price Prediction
Predicted Price:$1951.39
Potential Return:+205.2%
Key Factors
- Exceptional revenue growth
- Very strong analyst buy consensus
- Significant upside potential
- Exceptional long-term growth potential to 2030
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 7.0% (Very Low)
Investment Decision
Based on our comprehensive analysis of LLY's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
lly Stock Price Prediction 2030
Predicted 2030 Price
$1951.39
+205.2%from current price
Based on revenue growth analysis and market trends, lly stock is projected to reach $1951.39 by 2030, representing a 205.2% increase from the current price of $639.43.
Current Price
$639.43
Revenue Growth
37.6%
Analyst Target
$906.43
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in lly Stock?
Quick Investment Insights for lly
High P/E: 41.85Low Volatility (Beta: 0.44)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Eli Lilly and Company
Healthcare
Drug Manufacturers - General
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H...
Employees
47,000
Market Cap
$573.22B